Moderator note: This thread has been getting great engagement. Please remember to cite sources when making clinical claims.
No issues to report — carry on. 👍
Slightly tangential to ClinicalTrials.gov GLP-1 but RetaRick_CA reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
+1 to HealthEcon_DC. Especially the point about "Follow-up question: did you change anyth..." — I have seen the same in my own experience with ClinicalTrials.gov GLP-1.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsBookmarked 📌 The ClinicalTrials.gov info in this thread is essential. Coming back to this for sure.
Relevant to ClinicalTrials.gov GLP-1 trial — here is my latest bloodwork comparison:
Key improvements: A1C 7.6% → 5.5%, triglycerides 193 → 93 mg/dL, hsCRP 8.0 → 1.1 mg/L. All on tirzepatide for 9 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.